Abstract:BACKGROUND:An alarming increment in pathogenic resistance to existing anti-microbial agents is a serious problem and the treatment of these bacterial infections is becoming increasingly challenging. Therefore, there is an urgent need to develop novel antimicrobial agents.OBJECTIVE:As a part of our ongoing studies toward the development of novel antibacterial agents, the synthesis and antibacterial activity of a series of (Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives will be discussed in this study.METHOD:(Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives were designed, synthesized and evaluated for antibacterial activity. The structures were confirmed by IR, 1H NMR, 13C NMR and mass spectrometry. All of the synthesized compounds were evaluated in vitro using a 96-well microtiter plate and a serial dilution method to obtain their minimum inhibitory concentration (MIC) values against a variety of different strains, including multidrug-resistant clinical isolates.RESULTS:The antibacterial test in-vitro showed that most compounds in series 7 and 9 exhibited significant inhibitory activities against anaerobic bacteria (Streptococcus mutans) strains with a MIC value of 1 µg/mL. Compounds 7c and 9c showed the most potent activity against MRSA (3167 and 3506) with a minimum inhibitory concentration (MIC) value of 1 µg/mL, which is equivalent to moxifloxacin and greater than gatifloxacin, oxacillin and norfloxacin. Additionally, compound 9c showed potent antibacterial activity against Bacillus subtilis (aerobic bacteria) with a MIC value of 2 µg/mL.CONCLUSION:The work suggests that these type of rhodanine compounds had a better potent activity against MRSA compared with other perviously reported rhodanine derivatives, which might provide a valuable information for the development of new antibacterial agents against multidrug-resistant clinical isolates MRSA.

Novel 5-Methyl-2-phenylphenanthridium Derivatives As FtsZ-targeting Antibacterial Agents from Structural Simplification of Natural Product Sanguinarine.

Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors.

3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents

Application of natural-products repurposing strategy to discover novel FtsZ inhibitors: Bactericidal evaluation and the structure-activity relationship of sanguinarine and its analogs

Antibacterial activity of N-methylbenzofuro[3,2-b]quinoline and N-methylbenzoindolo[3,2-b]-quinoline derivatives and study of their mode of action

Structural Modification of Sanguinarine and Chelerythrine and Their Antibacterial Activity

Synthesis, Characterization, Biological Activity and Structure-activity Relationship of 6-N-heterocyclic Substituted Sanguinarine Derivatives

Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents

Novel Benzyl Phenyl Sulfide Derivatives As Antibacterial Agents Against Methicillin-Resistant Staphylococcus Aureus

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Synthesis and Biological Evaluation of Rhodanine Derivatives Bearing a Quinoline Moiety As Potent Antimicrobial Agents

Modification of 5-Methylphenanthridium from Benzothiazoles to Indoles As Potent FtsZ Inhibitors: Broadening the Antibacterial Spectrum Toward Vancomycin-Resistant Enterococci

Synthesis and Antibacterial Activity of Novel 4‐bromo‐1h‐indazole Derivatives As FtsZ Inhibitors

Identification of novel 4-substituted 7H-pyrrolo[2,3-d]pyrimidine derivatives as new FtsZ inhibitors: Bioactivity evaluation and computational simulation

Novel 5-Sulfonyl-1,3,4-thiadiazole-Substituted Flavonoids as Potential Bactericides and Fungicides: Design, Synthesis, Three-Dimensional Quantitative Structure-Activity Relationship Studies.

Design, Synthesis and Biological Activity Evaluation of Novel 2,6-Difluorobenzamide Derivatives Through FtsZ Inhibition

Re-engineering and synthesis of cytotoxic 2,3:7,8-di(alkylenedioxy)-extended analogs of quaternary sanguinarine chloride

Design, Synthesis of Novel 4,5-Dihydroisoxazole-containing Benzamide Derivatives As Highly Potent FtsZ Inhibitors Capable of Killing a Variety of MDR Staphylococcus Aureus.

Synthesis and Antimicrobial Evaluation of L-Phenylalanine-Derived C5-Substituted Rhodanine and Chalcone Derivatives Containing Thiobarbituric Acid or 2-Thioxo-4-thiazolidinone

Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.

Synthesis and Antibacterial Evaluation of Rhodanine-Based 5-Aryloxy Pyrazoles Against Selected Methicillin Resistant and Quinolone-Resistant Staphylococcus Aureus (MRSA and QRSA).